These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 19403380

  • 1. [A simple and efficient method for establishing a mouse model of orthotopic MB49 bladder cancer].
    Liang ZK, Zhang L, Hu ZM, Chen Z, Huang X, Shi XH, Tan WL, Gao JM.
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Apr; 29(4):627-30. PubMed ID: 19403380
    [Abstract] [Full Text] [Related]

  • 2. Optimizing syngeneic orthotopic murine bladder cancer (MB49).
    Günther JH, Jurczok A, Wulf T, Brandau S, Deinert I, Jocham D, Böhle A.
    Cancer Res; 1999 Jun 15; 59(12):2834-7. PubMed ID: 10383142
    [Abstract] [Full Text] [Related]

  • 3. Effects of acetylic salicylic acid and pentoxifylline on the efficacy of intravesical BCG therapy in orthotopic murine bladder cancer (MB49).
    Günther JH, Frambach M, Deinert I, Brandau S, Jocham D, Böhle A.
    J Urol; 1999 May 15; 161(5):1702-6. PubMed ID: 10210443
    [Abstract] [Full Text] [Related]

  • 4. Nonviral cytokine gene therapy on an orthotopic bladder cancer model.
    Wu Q, Mahendran R, Esuvaranathan K.
    Clin Cancer Res; 2003 Oct 01; 9(12):4522-8. PubMed ID: 14555526
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Optimization of the MB49 mouse bladder cancer model for adenoviral gene therapy.
    Loskog A, Ninalga C, Hedlund T, Alimohammadi M, Malmström PU, Tötterman TH.
    Lab Anim; 2005 Oct 01; 39(4):384-93. PubMed ID: 16197705
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Monitoring the response of orthotopic bladder tumors to granulocyte macrophage colony-stimulating factor therapy using the prostate-specific antigen gene as a reporter.
    Wu Q, Esuvaranathan K, Mahendran R.
    Clin Cancer Res; 2004 Oct 15; 10(20):6977-84. PubMed ID: 15501977
    [Abstract] [Full Text] [Related]

  • 11. The therapeutic potential of SA-sCD40L in the orthotopic model of superficial bladder cancer.
    Zhang Z, Xu X, Zhang X, Chen X, Chen Q, Dong L, Hu Z, Li J, Gao J.
    Acta Oncol; 2011 Oct 15; 50(7):1111-8. PubMed ID: 21247263
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Intravesical perfusion of recombinant adeno-associated virus-endostatin in treatment of bladder cancer: experiments with mice].
    Lu BX, Han RF, Tang Y, Lei MD, Li SZ.
    Zhonghua Yi Xue Za Zhi; 2008 Dec 02; 88(44):3157-8. PubMed ID: 19159603
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Immobilization of streptavidin-tagged bioactive hTNF-alpha on biotinylated mucosal surface of the bladder wall for treatment of superficial bladder cancer in mice].
    Chen Z, Tan WL, Huang X, Liang ZK, Xu CX, Gao JM.
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 May 02; 30(5):936-40. PubMed ID: 20501361
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.